GSK temporarily pulls FDA application for wider use of Avodart

11/23/2009 | Google

GlaxoSmithKline is suspending its FDA application to market Avodart for wider use in reducing the risk of prostate cancer in order to submit more information on the drug. GSK said it will immediately resubmit the application and make the same update to filings in the EU.

View Full Article in:

Google

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Director, Quality Regulatory Affairs
Cardinal Health
Chicago, IL
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC